Estrogen Receptor Alpha Protects Right Heart Under Lung Pressure

Estrogen Receptor Alpha Preserves Right Ventricle Microvessels

Estrogen receptor alpha (ERα) preserves the survival and movement of blood vessel cells in the right heart during pulmonary hypertension, according to a preclinical study by National Jewish Health published in Arteriosclerosis, Thrombosis, and Vascular Biology.

Pulmonary hypertension causes high blood pressure in the vessels of the lungs. That increased resistance forces the right ventricle to pump harder to push blood through pulmonary tissue, making long-term survival dependent on how well this specific chamber adapts to mechanical strain.

Researchers found that ERα allows endothelial cells lining cardiac blood vessels to survive, migrate, and maintain the small capillaries required to supply the right ventricle when workload rises.

Receptor Disruption Impairs Female Cardiac Adaptation

Disrupting normal ERα function triggered greater structural damage in female preclinical models than in males. The impaired female models showed elevated endothelial cell death, reduced capillary density, and larger abnormal right ventricular enlargement under sustained pressure.

These observations address a recognized clinical paradox in pulmonary medicine. Women develop specific forms of pulmonary hypertension more often than men, yet female patients frequently maintain better right ventricular function and survival rates over time.

The findings indicate that active ERα signaling provides direct structural support to female cardiac microvessels when the chamber faces elevated vascular resistance.

• Endothelial cells with disrupted ERα formed fewer vessel-like networks.
• Loss of receptor function reduced the capillary density required to oxygenate the stressed heart wall.
• Right ventricular enlargement was significantly more pronounced in female models lacking functional ERα.

Genetic Sequencing Maps Specific Survival Pathways

Single-nucleus ribonucleic acid (RNA) sequencing identified the specific internal biological pathways influenced by ERα signaling. Endothelial cells in females with impaired ERα showed reduced activity in pathways responsible for cell migration and vessel organization.

The same sequencing revealed an increase in genetic pathways linked to programmed cell death. Male models did not display these molecular shifts to the same extent, confirming that ERα plays a distinct, sex-specific role in cardiac endothelial maintenance.

Preserving an intact vascular network within the heart wall prevents tissue starvation while the right ventricle works against elevated pulmonary pressures.

Clinical Applications Require Human Investigation

These experimental findings establish a biological mechanism in laboratory models rather than an approved medical intervention for humans. Senior author Tim Lahm noted that while right ventricular function determines survival in pulmonary hypertension, clinicians currently have very few therapies tailored specifically to protect this chamber.

The published data do not support self-directed hormone adjustments, estrogen supplementation, or changes to prescribed pulmonary hypertension regimens. Translating these observations into targeted medical treatments will require clinical trials to assess safety and efficacy in patients.

Individuals managing cardiopulmonary or metabolic conditions should discuss their current medication protocols and cardiac monitoring plans with their treating physician.